Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Dec;59(12):1320-6.
doi: 10.1136/jcp.2005.029850.

Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations

Affiliations
Case Reports

Parvovirus B19 detected in Rosai-Dorfman disease in nodal and extranodal manifestations

Y Mehraein et al. J Clin Pathol. 2006 Dec.

Abstract

Sinus histiocytosis with massive lymphadenopathy (SHML), also designated as Rosai-Dorfman disease (RDD), is a rare benign reactive lymphoproliferative disorder. It is defined by a characteristic histopathology with sinus histiocytosis and haemophagocytosis known as emperipolesis. In histiocytes S100 is strongly expressed, whereas CD1a staining typically is negative. The disease mainly manifests at a single lymph node; however, multilocular and extranodal affection can occur. Causative infectious agents, and virus infections in particular, have repeatedly been suspected, although until now the origin of the disease has been unclear. Four cases of RDD (two nodal sites and two extranodal upper respiratory tract sites) were analysed for parvovirus B19 (B19) infection by immunohistochemistry to detect B19 capsid proteins VP1/VP2. In all the four cases, huge numbers of B19-positive cells were partly detected. The positive cells were identified either as lymphocytes or, in one extranodal case, also as respiratory epithelial cells. This is the first report of B19 infection in RDD tissue, indicating that B19 may be associated with the pathogenesis of SHML.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

References

    1. Rosai J, Dorfman R T. Sinus histiocytosis with massive lymphadenopathy; a newly recognized benign clinicopathological entity. Arch Pathol 19698763–70. - PubMed
    1. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai‐Dorfman disease): review of the entity. Semin Diagn Pathol 1990719–73. - PubMed
    1. McClain K L, Natkunam Y, Swerdlow S H. Atypical cellular disorders. Hematology (Am Soc Hematol Educ Program) 2004238–296. - PubMed
    1. Eisen R N, Buckley P J, Rosai J. Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai‐Dorfman disease). Semin Diagn Pathol 1990774–82. - PubMed
    1. Paulli M, Rosso R, Kindl S.et al Immunophenotyic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai‐Dorfman disease). Hum Pathol 199223647–654. - PubMed

Publication types

Substances